Medical Oncology

Doç. Dr. Nargız Majıdova

Doctor and researcher Medical Park İstanbul Onkoloji Hastanesi İstanbul

Lung NeoplasmsCarcinoma, Non-Small-Cell LungBreast NeoplasmsLiver NeoplasmsCarcinoma, HepatocellularCarcinoma, Renal CellKidney NeoplasmsPancreatic NeoplasmsSkin NeoplasmsBiliary Tract Neoplasms

Open institution page

Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Lung Neoplasms 9 publications

Source: OpenAlex / PubMed MeSHView publications
Carcinoma, Non-Small-Cell Lung 8 publications
Breast Neoplasms 8 publications
Liver Neoplasms 4 publications
Carcinoma, Hepatocellular 3 publications
Carcinoma, Renal Cell 2 publications
Kidney Neoplasms 2 publications
Pancreatic Neoplasms 2 publications
Skin Neoplasms 2 publications
Biliary Tract Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

Meme kanseri
Akciğer kanseri
Kolorektal kanserler
Mide kanseri
Pankreas kanseri
Prostat kanseri
Böbrek kanseri
Jinekolojik kanserler

Education and experience

From source

Experience

20162020 Samsun Ondokuz Mayıs Üniversitesi İç Hastalıkları Uzmanımedicalpark.com.tr
20202021 VM Medikal Park Samsun Hastanesi İç Hastalıkları Uzmanımedicalpark.com.tr
20212024 İstanbul Marmara Üniversitesi Tıbbi Onkoloji Uzmanımedicalpark.com.tr
20242026 Maltepe Medical Park Hastanesi Tıbbi Onkoloji Uzmanımedicalpark.com.tr
Experience2026 Medical Park İstanbul Onkoloji Hastanesimedicalpark.com.tr

Education

20092015 Samsun Ondokuz Mayıs Üniversitesi Tıp Fakültesimedicalpark.com.tr
20162020 Samsun Ondokuz Mayıs Üniversitesi İç Hastalıkları Uzmanlıkmedicalpark.com.tr
20212024 İstanbul Marmara Üniversitesi Tıbbi Onkoloji Uzmanlıkmedicalpark.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

SpecialtyMedical Oncologymedicalpark.com.trFrom source
Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
InstitutionMedical Park İstanbul Onkoloji Hastanesimedicalpark.com.trFrom source
Area of workLung NeoplasmsExtracted from 9 publications · Model version —From source
Publications92 publicationsOpenAlex, ORCIDFrom source
ORCID0000-0002-2575-5819ORCIDFrom source
Last synchronised4 November 2026 20:34https://www.medicalpark.com.tr/hekimler/nargiz-majidovamedicalpark.com.tr

Scientific work

Publications on Lung Neoplasms

92 publications

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis

Medicina, 2026

DOI 10.3390/medicina62050984 PMID 42195237 Open-access full textSource: OpenAlex
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study

Discover Oncology, 2026

DOI 10.1007/s12672-026-04842-3 PMID 41870760 Open-access full textSource: OpenAlex
Which patients with colorectal cancer develop brain metastases? A multicenter analysis of clinical and molecular predictors.

Journal of Clinical Oncology, 2026

DOI 10.1200/jco.2026.44.2_suppl.218 Open-access full textSource: OpenAlex
Clinicopathologic and molecular characteristics of colorectal cancer patients with brain metastases: a multicenter cohort study

Scientific Reports, 2026

DOI 10.1038/s41598-026-69206-x Open-access full textSource: OpenAlex
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab

Immunotherapy, 2026

DOI 10.1080/1750743x.2026.2662201 PMID 42011533 4 citations (Europe PMC) Open-access full textSource: OpenAlex
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study

Therapeutic Advances in Medical Oncology, 2026

DOI 10.1177/17588359261430583 PMID 41835339 1 citation (Europe PMC) Open-access full textSource: OpenAlex
Abstract PS5-02-08: Impact of Prior T-DM1 Exposure on the Efficacy of Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer

Clinical Cancer Research, 2026

DOI 10.1158/1557-3265.sabcs25-ps5-02-08 Source: OpenAlex
Abstract PS5-05-14: Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study

Clinical Cancer Research, 2026

DOI 10.1158/1557-3265.sabcs25-ps5-05-14 Source: OpenAlex
Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study

The Breast, 2026

DOI 10.1016/j.breast.2026.104936 PMID 42777557 Open-access full textSource: ORCID
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15134901 PMID 42452362 Open-access full textSource: ORCID

View all 92 publications

Other doctors working on these diseases

Memberships and more

Türk Tıbbi Onkoloji Derneği
European Society for Medical Oncology
Amerıcan Socıety of Clınıcal Oncology
Türk Tabipler Birliği

Source: medicalpark.com.tr

Ask Doctoria AI

Coming soon

In preparation for doctors, institutions and research teams. Examples of questions you will be able to ask:

Find the doctors with the most publications in Medical Oncology Find the researchers scientifically closest to this profile Find researchers for a multicentre study

Let’s improve this profile together

Every change is stored with its source, contributor and date.

Suggest a correction Add a publication Correct the institution Add a specialty Merge a duplicate record Claim profile

Last change: 31 yayın ORCID kimliğiyle eklendi Source: https://orcid.org/0000-0002-2575-5819
Contributor: Doctoria bot
Date: 6 November 2026 17:31